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Background: While obstetric fistula has been recognized as a major maternal morbidity since the 1980s, it has
become an indicator of access to and quality of women’ s health care.
Findings: Obstetric fistula still exists in low-income countries (LIC) because health care systems fail to provide
adequate family planning, skilled birth attendance, basic and emergency obstetric care, and affordable treatment of
fistula, while concurrently lacking social networks to serve as safety nets for affected girls and women [WHO, 2007].
Conclusion: This review explores the most recent published experience with respect to the definition of fistula, its
diagnosis, treatment, and management, and further steps for prevention of fistula on a global scale.
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An urogenital fistula is defined as an abnormal commu-
nication between the bladder, ureter, urethra, vagina,
and/or rectum with resulting incontinence of urine and/
or stool. It may occur as a sequela of childbirth or as a
result of surgical injury, malignancy, infection, trauma,
or endometriosis. The term obstetric fistula refers to fis-
tulae resulting from the ‘obstructed labor injury com-
plex’, which describes the injury that occurs when the
presenting fetal part becomes impacted against the bony
pelvis during labor causing hypoperfusion of the soft tis-
sues in between, resulting in ischemia, necrosis, and an
abnormal communication between two pelvic organs [2].
Not all obstetric fistulae result from obstructed labor. A
recent review of almost 6,000 cases of urogenital fistula
suggested that just over thirteen percent of fistulae were
iatrogenic, 80 % of which followed surgery for obstetric
complications including cesarean section (57 %), repair
of ruptured uterus (20 %), and hysterectomy for ruptured
uterus or obstetric indications (3 %), with the remainder
occurring during gynecologic surgery unrelated to preg-
nancy [3]. Of note, urogenital fistulae are often referred to* Correspondence: msh2154@cumc.columbia.edu
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fistula involves the bladder and vagina, rectovaginal the
rectum and vaginal, ureterovaginal the ureter and vagina,
and vesicouterine the bladder and uterus. Urogenital
fistulas are quiet varied and can include any and/or all of
the genitourinary system, but those involved are often
reflected by how the fistula is named.
Epidemiology, incidence, and prevalence
With the recognition of urogenital fistula as a public
health indicator related to both the availability and qual-
ity of women’s healthcare services, there has been much
interest in determining its incidence and prevalence
around the world. Fistula patients are a literal embodi-
ment of healthcare system failure to provide appropriate
maternal healthcare and delivery services, and as such,
fistula occurrence can be used as a measure to deter-
mine the quality of the healthcare system in a given area.
Commonly quoted numbers suggest that there are 3.5 mil-
lion women currently living with urogenital fistula and that
50,000 to 100,000 women develop fistula annually [4, 5]. A
recent meta-analysis estimated a pooled prevalence of 0.29
fistulae per 1000 reproductive age women in all regions
with a rate of 1.6/1000 in sub-Saharan Africa and 1.2/1000
in south Asia [6]. The pooled incidence was 0.09 fistulae
per 1000 recently pregnant women [6]. Prior to thisarticle distributed under the terms of the Creative Commons Attribution License
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cidence came from the 2000 Global Burden of Disease re-
port that suggested the incidence was 0.08 % of all births
and 2.15 % of births complicated by neglected obstructed
labor [7].
Current methods for assessing the prevalence of urogeni-
tal fistula include self-reporting and general communica-
tion with surgeons, studies by advocacy groups, and
reviews of hospital services; they mostly use community or
facility sampling or a combination of both [8]. Because of
the relative rarity of fistula, the desire of affected women to
hide their condition, and the poor quality of data collection
methods in areas where women are affected, obtaining
quality data is very difficult [8]. A recent review published
on determining the worldwide incidence and prevalence of
urogenital fistula suggests that data need to be collected
through routine surveillance and monitoring systems that
are currently integrated into established health systems
and national programs [8]. An example given is the Demo-
graphic and Health Surveys that many countries conduct,
which include home births; questions should be added to
the survey regarding urogenital fistula to garner better data
[8]. Additionally, follow-up data collection on women seek-
ing care is also important to track the met need for surgical
care and to observe how targeted prevention or treatment
interventions are affecting outcomes related to urogenital
fistula [8]. The aforementioned review also suggests that
fistula care be part of the full continuum of maternal health
services provided in maternity wards, and that providers
should be trained to assess for urogenital fistula at postpar-
tum visits [8].
The global public health community has recognized
the necessity of good data collection regarding urogeni-
tal fistula not only in terms of incidence and prevalence,
but also in terms of availability of centers for fistula care
and providers capable of providing high quality treat-
ment. As such, the WHO developed the Global Fistula
Map in an attempt to show not only where women are
affected around the world, but also where providers are
available [9]. The map was unable to be reproduced for
this review, but can be accessed online at http://
www.globalfistulamap.org/. Information on how the data
was collected is explained on the website and the actual
data itself can be downloaded for review.
Risk factors and causes
Obstetric fistula is associated with age < twenty years,
first pregnancy, labor greater than 24 h, delivery at
home, height < 150 cm (<59 in.), low levels of maternal
education, poor contraceptive utilization, low rates of
antenatal care utilization, and having a male fetus [10–12].
A given woman’s risk for obstetric fistula formation is also
determined by her overall health, socioeconomic status,
and her access to and utilization of health care services[11]. While the immediate cause of obstetric fistula is the
lack of safe labor and delivery services, root causes include
poor health care infrastructure such as transportation and
communication, as well as cultural norms that devalue
women, including lack of female autonomy, economic and
social independence, and education [11].
Socioeconomic and psychosocial implications
Urogenital fistula follows acute physical trauma, but it
causes continued physical and psychosocial trauma
through exclusion from social networks, divorce, impov-
erishment, and major depression [12]. Role loss, isola-
tion, and economic deprivation were the most common
consequences for women with fistula, and the majority
of these women were abandoned by husbands, shunned
by family, and struggled severely with hygiene associated
with incontinence and wound care, as well as frequent
infections [13]. The women suffer from post-traumatic
stress disorder, social isolation, feeling like the object of
stigma, low quality of life, and general mental health
dysfunction, including suicidal ideation [14–16].
Diagnosis, treatment and management
Timing and symptomatology
Women with urogenital fistula classically present with
continuous urinary incontinence, as compared to incon-
tinence with a valsalva maneuver, or stress urinary incon-
tinence, which is common after normal labor and delivery
[17, 18]. While timing of presentation after delivery can be
affected by socioeconomic as much as clinical factors, it
can also be determined by the type of fistula from which a
woman suffers. For example, fistula from cesarean delivery
may present seven to ten days post-operatively due to for-
mation of a fistulous tract over time, while obstetric fistula
due to obstructed labor can usually be noted immediately
after delivery [1, 19, 20]. Fistulas that involve the uterus
can involve irregular bleeding patterns and loss of blood
in urine [19, 21]. Additionally, if the ureter is transected,
the presentation will likely occur immediately post-
operatively as an intra-abdominal urinoma when the
patient begins to experience the pain, pressure, and symp-
toms produced by the mass effect of extravasated urine,
but may not present as a fistula until the anomalous tract
has formed with the vagina or another body cavity [19].
Diagnosis
Diagnosis involves a full medical and social history, in-
cluding details about the incident pregnancy, the labor
course, the delivery, and the fetal outcome. Review of
systems should be performed with attention to urinary
and fecal symptoms, as well as general mobility and
musculoskeletal function [1]. The physical examination
begins with collecting vital signs and performing a
neurologic and gait evaluation [1]. Visual inspection
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evaluation for perineal dermatitis, ulceration, infection,
and scarring from prior episiotomy, circumcision, or fis-
tula repair [1]. The examiner should then proceed to ab-
dominal and bimanual examination noting the severity
and nature of vaginal and rectal scarring; location, size,
and number of fistulae; and involvement of crucial struc-
tures such as the urethral sphincter, anal sphincter, and
urethra itself [1]. Further diagnostic testing may be ne-
cessary, such as a vaginal speculum exam for improved
exposure, or a dye test [22]. Dye tests generally involve
back-filling the bladder and temporarily occluding the
urethra for evaluation of dye leakage. If the fistula can-
not be immediately located, some authors recommend
vaginal packing, with the location of dye leakage on the
pack used to help narrow down the fistula position [17].
Additionally, oral pyridium or intravenous indigo car-
mine can be administered to assess ureteral involvement
[17, 19]. Hemoglobin determination and testing for
sexually transmitted infections are also recommended,
as the former is important for pre-operative planning,
and the latter because sexually transmitted infections
can be the cause of a fistula (and their treatment may
allow for spontaneous fistula closure), and they can also
cause friability of the tissue which will complicate fistula
closure. Additionally, patients who are HIV positive may
require treatment and rehabilitation prior to surgery to
improve their surgical outcomes.
Treatment
The primary goal of fistula treatment is continence.
Obtaining continence generally requires surgery, but
may be achieved by conservative treatment with cathe-
ters or stents, or require a more aggressive diversionary
procedure [1, 23].
Conservative management
Women with a small simple fistula discovered shortly
after delivery, or those presenting to a facility with
obstructed labor, may be treated conservatively with in-
sertion of a Foley catheter for somewhere between two
and six weeks, twice daily sitz baths, high volume oral
intake of fluids, and treatment of any obvious concur-
rent infections [1]. Currently available data are of poor
quality and no clear recommendations can be made as
to whether initial conservative management with a Foley
catheter is appropriate or effective [24]. However, since
1942, papers have been published suggesting use of a
Foley catheter as a method of assisting spontaneous
closure of vesicovaginal fistulae less than one centimeter
in size [24]. Similarly, ureteral stents placed for one to
two months may result in spontaneous resolution of fis-
tulas involving the ureter in greater than half of cases
[17, 23]. Ureteral stents are usually placed, in thiscontext, by way of cystoscopy, which may not be avail-
able in LIC.
Surgical management
For most patients, surgery is the only option. The over-
riding principle of fistula repair is that the first attempt
offers the best chance of successful closure [1]. The basic
principles of surgical repair are: 1) achieving adequate
exposure, 2) mobilizing the fistula from surrounding scar
tissue, so that 3) a tension-free closure can be performed
that is water-tight [1, 4].
Timing of surgery
While the traditional teaching is that patients undergo sur-
gery three months after diagnosis to allow time for the fis-
tulae to become less inflamed, more recent data suggest
that fistulae be repaired immediately if diagnosed within
72 h of delivery, or even within the three month window,
as repair within this timeframe prevents a significant
amount of the negative social, economic, and physical se-
quelae associated with incontinence [17, 19, 23, 25]. Some
patients, however, may present years after fistula forma-
tion. For these patients, if there is no residual edema,
erythema, or persistent granulation tissue, and no need
for treatment of infections, anemia, or malnutrition,
surgery can be pursued without additional delay [19].
Iatrogenic fistulae should undergo surgical repair with
diagnosis, unless the fistula is the result of retained su-
ture. In that case, waiting until the suture is resorbed is
in order [3, 19].
Pre-operative care
The WHO advises pre-operative management include
anesthesia evaluation, skin preparation, hair clipping,
high oral fluid intake, bowel preparation, and nothing by
mouth from midnight of the night before surgery [1].
Issues such as nutritional supplementation and pre-
operative estrogen usage, as well as transfusion or sup-
plementation for anemia and empiric treatment with
anti-malarials, antibiotics, or antiparasitics are topics for
further research.
Surgical methods
The WHO guidelines recommend a vaginal approach to
urogenital fistula repair. The optimal surgical position is
high lithotomy, and the optimal anesthetic technique is
regional [1]. Vaginal repair is associated with less blood
loss, results in shorter operative time, leads to decreased
use of analgesics, and overall accounts for shorter hospital
length of stays [19]. Various antibiotic regimens, which in-
clude single-dose gentamicin, appear to be equally effective
at decreasing post-operative urinary tract infections and
improving leakage and incontinence profiles on discharge
from the hospital [19, 26]. Commonly performed initial
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ment of retractors that assist with visualization, Foley
catheterization to divert urine from the operative field,
protection of the ureters with stents, and placement of
a probe into the fistula to delineate its course and es-
tablish its boundaries [17].
Closure methods include the Latzko technique (partial
colpocleisis without excision of the fistula tract), layered
closure (excision of the fistulous tract), and use of flaps,
which may be biologic (such as the Martius flap—a labial
fat pad), but also include more recent experimentation
with synthetic materials [17, 19, 23]. Studies have shown
the Latzko technique to be quite effective with success
rates quoted as 93 to 100 %, and placement of the Martius
flap to have 70 – 100 % success rates, with the caveat that
the latter method is used in the setting of more compli-
cated fistulae with greater fibrosis and necrosis, or lack of
tissue available for closure [19]. There is also a role for
more invasive procedures that necessitate an abdominal
approach for patients with reduced bladder capacity or
pliability, involvement of the ureter, trigone, ureteral ori-
fice, or cervix, and inability to access the fistula by way of
the vagina, or for patients who have not achieved contin-
ence after multiple repairs or those whose fistula is too
large, or the remaining tissue is too scarce, that anatomic
closure is not possible [17, 27].Minimally invasive surgery
Although minimally invasive surgery (MIS) such as lapar-
oscopy and robotics is more accessible in high-income
countries (HIC), a group in India is utilizing MIS to repair
urogenital fistulae resulting from obstetric complications
[28]. This group reportedly closed vesicovaginal fistulae
with a single layer continuous laparoscopic suture with
interposition of an omental flap; urethral catheters were
left in situ for a month post-operatively [28]. As the cap-
acity for MIS in LIC builds, it will be interesting to see
how this experience contributes to the surgical literature.Post-operative care
The WHO guidelines recommend regularly scheduled
vital signs, pad checks and catheter monitoring for geni-
tourinary bleeding, intravenous fluids, strict tracking of
intake and output of fluids, and regularly scheduled an-
algesia for pain control, which will allow earlier patient
mobility [1]. Patients are encouraged to continue to
maintain very high fluid consumption in the early days
following surgery, and the catheter is advised to be left
in situ for a minimum of 10 – 14 days, with removal of
any necessary vaginal packing after 24 – 72 h [1, 19, 26].
There are no recommendations regarding post-operative
antibiotic use, but some research suggests that if used,
antibiotics should cover all vaginal flora [17].Outcomes
No straightforward framework exists for analyzing the
determinants of successful fistula treatment and out-
comes. This also applies to fistula classification—no gen-
erally accepted method exists: there are currently 25
proposed systems in practice, none of which were devel-
oped based on empiric evidence or with prognosis in
mind [29]. Standardization of terminology regarding
urogenital fistula will not only allow development of an
evidence-based prognostic classification system, but will
also facilitate research, guideline development, and the
analysis of clinical outcomes to determine the safety, ef-
ficacy, and quality of preventative, diagnostic, and treat-
ment interventions [24, 30]. Even the definitions of
‘success’ and ‘failure’ of fistula treatment are poorly de-
fined; many studies define success as physical closure of
the fistula while others define success as continence im-
mediately after surgery and then at a later point in time.
These assessments are made by back-filling the bladder
with dye and evaluating leakage and continence after
catheter removal; the time point at which this exam is
performed is usually at surgery to confirm fistula clos-
ure, and then two weeks post-operatively.
Despite the lack of uniform definitions of type of fistula
and measures of success, if success is defined as physical
closure of the fistula, then the literature reports a 55 % to
95 % closure rate with an average success rare of about
85 % [30]. If success is defined as urinary continence then
outcomes range from about a 40 % to 90 % success rate
with an average success rate of about 70 % [30]. According
the WHO guidelines, when establishing a fistula treatment
program, it is expected that the closure rate for fistula
should be 85 % and the continence rate should be 90 %
after a patient’s first fistula repair surgery [1]. Clinical fac-
tors that can affect surgical outcome and success rates in-
clude degree of urethral involvement (some damage
versus circumferential involvement); size, location, and
number of fistulae; amount of scar tissue and remaining
healthy tissue, including bladder capacity; and whether or
not the patient has previously undergone repair [30].
Psychosocial
Beyond documenting the distress experienced by fistula
patients, researchers are implementing interventions to
improve the mental health of this population. A Tanzanian
trial of a six-session treatment plan based on psychological
theory (cognitive behavioral therapy) was integrated into
the clinical flow of a fistula ward (two sessions pre-
operatively, four sessions post-operatively) and conducted
by a non-specialist mental health provider, to improve men-
tal health outcomes for fistula survivors [31]. The ratings
from participants were very positive. While that study
worked with patients individually, other studies have looked
at group therapy and also achieved measureable success
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very important for fistula patients and can be executed con-
currently with surgical treatment during the time when pa-
tients are preparing for and recovering from surgery [31].
Physiotherapy
The WHO practice guidelines recommend including
physiotherapy as part of the treatment program (deep
breathing, hip stretches, lower extremity range of mo-
tion stretches, and core strengthening exercises) as well
as post-operative workouts that include sitting, standing,
walking, and balancing, with graduated strength training,
and a detailed program of special movement, position-
ing, and passive stretches for patients affected by
contractures and nerve injuries [1]. A study of pre- and
post-operative health education and physiotherapy of
urogenital fistula patients reported that those who
underwent physiotherapy were almost three times more
likely to recover with less post-operative stress incontin-
ence, and in a follow-up study conducted by the same
group a year later, the results were maintained and qual-
ity of life had significantly improved [33, 34].
Socioeconomic practices & reintegration
The guiding principles for reintegration programs are that
patients should be taught self-sustaining skills, which may
require literacy training or workshops in making clothes
or crafts. These skills become especially important for
women who are single and no longer have the ability to
bear children or function as homemaker, and who other-
wise have no one to support them. They should be offered
counseling services and should be helped to reintegrate
into their social support network, which includes their
communities and families, but might also involve enroll-
ment in a women’s or fistula survivors support group [1].
Currently utilized interventions include training in income
generating skills, literacy training, and microcredit pro-
grams, as well as post-operative financial support in the
form of clothing, supplies, food, water, and actual stipends
[35]. While data in the area of economic repercussions of
fistula are lacking, recent research from Tanzania reported
that fistula patient’s hopes and concerns about the future
are primarily related to their ability to work, in addition to
social acceptance and future fertility [13, 36, 37].
Post-fistula
Some data exist on long-term follow-up of fistula patients
after repair. A Nigerian study evaluated 150 women six
months after repair to assess quality of life, physical health,
mental health, social health, and environment (available
income, ability to perform activities of daily living, and
level of participation in leisure activities), comparing those
indicators before and after surgery; the results were sig-
nificantly improved on all measures except ‘environment’[38]. A study of Ethiopian women reported that, the ma-
jority felt a dramatic sensation of relief and happiness fol-
lowing repair, yet some continued to experience mental
anguish, stigma, and physical problems regardless of the
outcome of the procedure. All women suffered intense
fear of developing another fistula, most commonly from
sex or childbirth. Despite this, the majority of women had
sex or planned to, while a smaller cohort avoided inter-
course and childbearing, thus subjecting them to isolation,
marital conflict, and/or economic vulnerability [39].
A study of fertility in 32 women with fistula from
Malawi showed that about half of pregnancies conceived
with an active fistula, and 70 % of those conceived post-
repair, ended in spontaneous abortion or perinatal death
[40]. Findings suggest that pregnancies conceived post-
repair may result in poor outcomes years out from sur-
gery; whether these results are related to fistula or occur
from coincident damage to the pelvis or some other eti-
ology is not clear. Data on contraception use in women
with fistula or post fistula repair is scarce. However, a
study of almost 200 women in Nigeria, showed that al-
most all knew about contraception, but less than half ac-
tually utilized it, suggesting that contraceptive uptake
after fistula repair was poor for fear of adverse effects
(41 % of participants), desire for fertility (30 %), religious
prohibition (22 %), cultural beliefs (25 %), and partner
disapproval (36 %) [41]. No studies were found on inter-




Whether the fistula results from poor labor and delivery
care or poor surgical technique, both are avoidable, and
the key is prevention. Improved access to high-quality
emergency obstetrical care including cesarean section is
essential, but so is improved access to family planning
services [25]. Over the longer term, attention should be
devoted to developing programs that combat the root
causes of fistula formation including improved educa-
tion, economic opportunity, and gender equality for
women [25]. While many of the factors leading to fistula
formation may be out of the control of the individual
woman, the decision to seek care for a dysfunctional
labor falls to the patient and birth attendant. Seeking
timely care for prolonged labor is a critical component of
obstetrical fistula prevention programs in resource-limited
settings [25]. To achieve the goal of overcoming this initial
delay to care, patients must value the services provided by
health institutions and understand the consequences of
not seeking care in a time-sensitive fashion. To accom-
plish this, the care women anticipate receiving must be
effective and of high quality, and be socially, physically,
and economically accessible. Overcoming these barriers
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and the greater community regarding dysfunctional labor
and the risk of fistula [25].
A recent review article examined current evidence
supporting fistula prevention strategies in sub-Saharan
Africa [42]. The authors advise promoting a minimum
of post-primary education for girls; providing sexual
education that includes information about fistula; edu-
cating communities about cultural, social, and physio-
logical factors that influence and contribute to fistula;
delaying early marriage and childbirth; eradicating mal-
nutrition; and defining time limits for labor at home
without progress [42]. The health system based strat-
egies that have shown success in prevention of fistula in-
clude scaling up access to, availability of, and provision
of emergency obstetric care; provision of affordable, safe,
and timely interventions for women in need of care; re-
ducing the distance to access care; and providing afford-
able transportation to health facilities [42]. Clearly,
additional training or re-training of surgical providers is
also crucial, since iatrogenic fistulae due to poor surgical
technique are also preventable.
In terms of actual interventions to prevent fistula that
have been published, there exist a few. One author ap-
plied a fistula index he developed, which is the multipli-
cation of a given patient’s height in centimeters by her
intertuberous distance (the distance between the ischial
tuberosities of her pelvis), which was measured by the
number of knuckles on the surgeon’s hand that he could
fit between the pelvic bones [43]. He applied his index in
a case-controlled study of 39 fistula patients and 54 con-
trols with normal vaginal deliveries [43]. His results were
significantly different between the groups, which was
not the case when height alone was compared, suggest-
ing that such a measure of clinical pelvimetry could be
useful in identifying women at risk for fistula develop-
ment [43]. Another study conducted in Niger employed a
community-mobilization program to reduce maternal and
neonatal mortality and reduce urogenital fistula formation
[44]. The intervention utilized village volunteers to iden-
tify and evacuate women with protracted labor, provide
education, and collect data on pregnancies, births, and
deaths [44]. Over three years the intervention significantly
reduced maternal and perinatal mortality and reduced the
occurrence of fistula from seven cases in the first six
months of the study to zero cases in the next 24 months
[44]. These interventions suggest that some combination
of prenatal risk assessment and education with access to
emergency obstetrical care can reduce and potentially pre-
vent urogenital fistula from obstetric causes.
Training & facility capacity
Even though efforts have been underway to address the
problem of urogenital fistula on a global scale for at least30 years, it was not until 2003 that the United Nations
established the Campaign to End Fistula, and it was not
until almost ten years later that attention was paid to issues
such as the availability of providers and facilities to address
the issue. Thus, WHO developed the Global Fistula Map
to assess how many providers provided fistula repair ser-
vices and to provide an illustration of available services for
women with fistula [43]. The Map demonstrates that cur-
rently, despite increased international attention to the
issue, the number of women with fistula is increasing be-
cause the number of repairs is less than the number of
new cases [22]. It is estimated that up to 80 % of women
living with fistula do not receive appropriate care [22, 45].
Given the lack of providers, the International Federation of
Gynecology and Obstetrics, published a competency-based
fistula-training manual in 2011 [22]. The manual, available
on their website at no cost, is meant to promote
standardization of surgical training for fistula repair and
increased the number of appropriately trained providers
able to provide high quality surgical repair [22, 46].
The next question on the topic of training and cap-
acity building is how much money will programs cost,
and what results can be expected from the investment.
On the issue of what gains can be expected from pre-
venting fistula, a recent paper was published on the sur-
gically avertable burden of obstetric conditions in low
and middle-income regions (LMIC) [47]. This manu-
script examines five conditions (maternal hemorrhage,
obstructed labor, obstetric fistula, abortion, and neonatal
encephalopathy) and uses demographic and epidemio-
logical data from the 2010 Global Burden of Disease
study to estimate avertable disability adjusted life years
(DALYs)—or years of healthy life lost caused by the
burden of a disease [47]. The analysis suggests that 37 %
of DALYs are avertable by the provision of universal, qual-
ity obstetric surgery in LMIC. The study suggests that
obstructed labor and obstetric fistula have the highest
rates of avertable burden and that sub-Saharan Africa and
South Asia carry the largest proportion of this burden
[47]. According to these authors, 1,121,346 DALYs (100 %
of associated DALYs) and 996,555 DALYs (89 % of associ-
ated DALYs) would be averted if quality obstetric surgical
services were available to prevent fistula formation [47].
As for cost estimates, it has been suggested that the in-
vestment required to scale up provision of comprehensive
universal obstetric care through from the prenatal through
postnatal period in the 75 LMIC most in need of such
care would require 39 billion dollars [48]. For comparison,
as of 2012 UNAIDS estimates that 122.5 billion dollars
had been invested in the global HIV/AIDS response [49].
Ethical considerations
Fistula patients deserve high quality care when they
present for fistula treatment. As such, a bill of rights for
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ethics for the fistula surgeon [50–52]. The bill of rights
states that fistula patients should be treated with com-
passion, dignity, and respect; they should have a right to
privacy and to full information and education regarding
their condition; they should have the right to direct their
own care—including refusal of treatment; and they have
the right to receive high quality care, and to be fed,
clothed, and sheltered during that process [51]. The
code of ethics of the fistula surgeon holds the provider
to the standard of providing the highest quality care to
the fistula patient and holding her welfare above all else;
treating her with dignity, respect, compassion, honesty,
and keeping her care confidential; taking responsibility
for her total care including appropriate pre-operative
and follow-up care; to not experiment on her or provide
care in which the surgeon is not trained; to be commit-
ted to evidence-based care and to be willing to alter
methods based on best-practice guidelines; to not take
advantage or allow others to take advantage of the fistula
patient (physically, emotionally, economically, sexually);
to exercise good stewardship over the financial resources
entrusted to them for the care of the fistula patients; to
work as part of a fistula care team and obey the laws of
the country in which they practice; and to be an advo-
cate on behalf of fistula patients to help remove barriers
that hinder access to emergency obstetrical care [50].
Future research
More research would improve clinical care as well as the
full spectrum of supportive care services that accompany
fistula treatment, such as psychosocial and economic sup-
port, in addition to guiding the training and health system
capacity building expected by the global community. That
being said, specialists in the field formulated recommen-
dations regarding the clinical topics they feel would most
benefit from rigorous controlled trials, which include: the
“efficacy/safety of short-term catheterization; efficacy of
surgical and nonsurgical therapies for urinary incontin-
ence; technical measures during fistula repair to reduce
the incidence of post-surgery incontinence; identification
of predictive factors for ‘incurable fistula’; usefulness of
urodynamic studies in the management of urinary incon-
tinence; incidence and significance of multi-drug resistant
bacteria in the fistula population; primary management of
small, new fistulae by catheter drainage; and antibiotic
prophylaxis in fistula repair” [53].
Conclusion
This review has addressed the multifaceted nature of
urogenital fistula and that it may be a natural sequela of
obstructed labor or iatrogenic. Fistula formation is pri-
marily rooted in poor access to quality labor and delivery
care. It deeply affects and disorganizes women’s lives,plaguing the poorest and most marginalized populations,
and clinical management of urogenital fistula is in dire
need of an evidence-base, despite published guidelines.
In conclusion, successful treatment of a fistula patient
not only means closure of her fistula, but incorporation
into a comprehensive treatment program aimed at
achieving continence, mental health, physical rehabilita-
tion, and socioeconomic training and support. Urogeni-
tal fistula resulting from childbirth is an historical
footnote in HIC, and the provision of high-quality com-
prehensive emergency obstetrical care in LIC would ren-
der it extinct on a global scale. With a manageable price
tag of 39 billion dollars, a massive burden of death and
disability would be lifted from the human race, resulting
in the survival of healthy women and children who bring
near limitless potential for their own and the common
good.
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